Hofseth Biocare establishes Swiss subsidiary, appoints CEO

The setup in Switzerland is in line with Hofseth’s international strategy, with the country being widely recognized as a major biotech and life science hub.

For the last seven years Tanja Schaffer has held the position of VP of Global Pharmaceuticals Industry within Swiss group DKSH, also known as DiethelmKellerSiberHegner.
For the last seven years Tanja Schaffer has held the position of VP of Global Pharmaceuticals Industry within Swiss group DKSH, also known as DiethelmKellerSiberHegner.Foto: DKSH
Published 17 September 2021, 08:22Updated 17 September 2021, 08:22
Hofseth BiocareRoger HofsethSwitzerlandNorwaybiotech